Could cheaper MRI scans spot a dangerous artery disease?

NCT ID NCT05854927

Recruiting now Diagnosis Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether lower-resolution MRI scans can still reliably detect giant cell arteritis, a serious inflammation of arteries that can cause blindness or stroke. Researchers will compare different MRI techniques in 133 adults suspected of having the disease. If lower-resolution scans work well, more hospitals could offer this test, leading to faster diagnosis and treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 3D T1 MRI sequences with contrast, fat saturation, and black blood
What this could lead to: If successful, this could allow more hospitals to use MRI for diagnosing giant cell arteritis, speeding up treatment and preventing complications.
What could go wrong: This is an early-stage diagnostic study, not a treatment trial. Lower-resolution images may miss subtle signs of inflammation, reducing accuracy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Giant Cell Arteritis temporal arteritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GIANT CELL ARTERITIS

Contacts and locations

Locations

Hôpital Fondation Adolphe de Rothschild
RECRUITING

Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.